The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Embolic Microspheres Market Research Report 2024
Synopsis
Embolic microspheres are superior permanent or resorbable particulate embolic agents available in different well-calibrated size ranges for precise occlusion. And it may comprise additional functionality such as drug loading and elution capability, specific mechanical properties, imageability or radioactivity
The global Embolic Microspheres market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Embolic Microspheres is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Embolic Microspheres is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Embolic Microspheres include Nippon Kayaku, Boston Scientific, CeloNova BioSciences, BTG Corporate, Merit Medical Systems, ABK Biomedical, Terumo Corporation, BioSphere Medical and Tepha, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Embolic Microspheres, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Embolic Microspheres.
Report Scope
The Embolic Microspheres market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Embolic Microspheres market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Embolic Microspheres manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Nippon Kayaku
Boston Scientific
CeloNova BioSciences
BTG Corporate
Merit Medical Systems
ABK Biomedical
Terumo Corporation
BioSphere Medical
Tepha
Angio Dynamics
Jiangsu Hengrui Medicine
Segment by Type
Liquid
Solid
Segment by Application
Hospitals and Clinics
Research Institution
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Embolic Microspheres manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Embolic Microspheres in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Embolic microspheres are superior permanent or resorbable particulate embolic agents available in different well-calibrated size ranges for precise occlusion. And it may comprise additional functionality such as drug loading and elution capability, specific mechanical properties, imageability or radioactivity
The global Embolic Microspheres market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Embolic Microspheres is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Embolic Microspheres is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Embolic Microspheres include Nippon Kayaku, Boston Scientific, CeloNova BioSciences, BTG Corporate, Merit Medical Systems, ABK Biomedical, Terumo Corporation, BioSphere Medical and Tepha, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Embolic Microspheres, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Embolic Microspheres.
Report Scope
The Embolic Microspheres market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Embolic Microspheres market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Embolic Microspheres manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Nippon Kayaku
Boston Scientific
CeloNova BioSciences
BTG Corporate
Merit Medical Systems
ABK Biomedical
Terumo Corporation
BioSphere Medical
Tepha
Angio Dynamics
Jiangsu Hengrui Medicine
Segment by Type
Liquid
Solid
Segment by Application
Hospitals and Clinics
Research Institution
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Embolic Microspheres manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Embolic Microspheres in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Embolic Microspheres Market Overview
1.1 Product Overview and Scope of Embolic Microspheres
1.2 Embolic Microspheres Segment by Type
1.2.1 Global Embolic Microspheres Market Value Comparison by Type (2024-2030)
1.2.2 Liquid
1.2.3 Solid
1.3 Embolic Microspheres Segment by Application
1.3.1 Global Embolic Microspheres Market Value by Application: (2024-2030)
1.3.2 Hospitals and Clinics
1.3.3 Research Institution
1.4 Global Embolic Microspheres Market Size Estimates and Forecasts
1.4.1 Global Embolic Microspheres Revenue 2019-2030
1.4.2 Global Embolic Microspheres Sales 2019-2030
1.4.3 Global Embolic Microspheres Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Embolic Microspheres Market Competition by Manufacturers
2.1 Global Embolic Microspheres Sales Market Share by Manufacturers (2019-2024)
2.2 Global Embolic Microspheres Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Embolic Microspheres Average Price by Manufacturers (2019-2024)
2.4 Global Embolic Microspheres Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Embolic Microspheres, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Embolic Microspheres, Product Type & Application
2.7 Embolic Microspheres Market Competitive Situation and Trends
2.7.1 Embolic Microspheres Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Embolic Microspheres Players Market Share by Revenue
2.7.3 Global Embolic Microspheres Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Embolic Microspheres Retrospective Market Scenario by Region
3.1 Global Embolic Microspheres Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Embolic Microspheres Global Embolic Microspheres Sales by Region: 2019-2030
3.2.1 Global Embolic Microspheres Sales by Region: 2019-2024
3.2.2 Global Embolic Microspheres Sales by Region: 2025-2030
3.3 Global Embolic Microspheres Global Embolic Microspheres Revenue by Region: 2019-2030
3.3.1 Global Embolic Microspheres Revenue by Region: 2019-2024
3.3.2 Global Embolic Microspheres Revenue by Region: 2025-2030
3.4 North America Embolic Microspheres Market Facts & Figures by Country
3.4.1 North America Embolic Microspheres Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Embolic Microspheres Sales by Country (2019-2030)
3.4.3 North America Embolic Microspheres Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Embolic Microspheres Market Facts & Figures by Country
3.5.1 Europe Embolic Microspheres Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Embolic Microspheres Sales by Country (2019-2030)
3.5.3 Europe Embolic Microspheres Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Embolic Microspheres Market Facts & Figures by Country
3.6.1 Asia Pacific Embolic Microspheres Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Embolic Microspheres Sales by Country (2019-2030)
3.6.3 Asia Pacific Embolic Microspheres Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Embolic Microspheres Market Facts & Figures by Country
3.7.1 Latin America Embolic Microspheres Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Embolic Microspheres Sales by Country (2019-2030)
3.7.3 Latin America Embolic Microspheres Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Embolic Microspheres Market Facts & Figures by Country
3.8.1 Middle East and Africa Embolic Microspheres Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Embolic Microspheres Sales by Country (2019-2030)
3.8.3 Middle East and Africa Embolic Microspheres Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Embolic Microspheres Sales by Type (2019-2030)
4.1.1 Global Embolic Microspheres Sales by Type (2019-2024)
4.1.2 Global Embolic Microspheres Sales by Type (2025-2030)
4.1.3 Global Embolic Microspheres Sales Market Share by Type (2019-2030)
4.2 Global Embolic Microspheres Revenue by Type (2019-2030)
4.2.1 Global Embolic Microspheres Revenue by Type (2019-2024)
4.2.2 Global Embolic Microspheres Revenue by Type (2025-2030)
4.2.3 Global Embolic Microspheres Revenue Market Share by Type (2019-2030)
4.3 Global Embolic Microspheres Price by Type (2019-2030)
5 Segment by Application
5.1 Global Embolic Microspheres Sales by Application (2019-2030)
5.1.1 Global Embolic Microspheres Sales by Application (2019-2024)
5.1.2 Global Embolic Microspheres Sales by Application (2025-2030)
5.1.3 Global Embolic Microspheres Sales Market Share by Application (2019-2030)
5.2 Global Embolic Microspheres Revenue by Application (2019-2030)
5.2.1 Global Embolic Microspheres Revenue by Application (2019-2024)
5.2.2 Global Embolic Microspheres Revenue by Application (2025-2030)
5.2.3 Global Embolic Microspheres Revenue Market Share by Application (2019-2030)
5.3 Global Embolic Microspheres Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Nippon Kayaku
6.1.1 Nippon Kayaku Corporation Information
6.1.2 Nippon Kayaku Description and Business Overview
6.1.3 Nippon Kayaku Embolic Microspheres Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Nippon Kayaku Embolic Microspheres Product Portfolio
6.1.5 Nippon Kayaku Recent Developments/Updates
6.2 Boston Scientific
6.2.1 Boston Scientific Corporation Information
6.2.2 Boston Scientific Description and Business Overview
6.2.3 Boston Scientific Embolic Microspheres Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Boston Scientific Embolic Microspheres Product Portfolio
6.2.5 Boston Scientific Recent Developments/Updates
6.3 CeloNova BioSciences
6.3.1 CeloNova BioSciences Corporation Information
6.3.2 CeloNova BioSciences Description and Business Overview
6.3.3 CeloNova BioSciences Embolic Microspheres Sales, Revenue and Gross Margin (2019-2024)
6.3.4 CeloNova BioSciences Embolic Microspheres Product Portfolio
6.3.5 CeloNova BioSciences Recent Developments/Updates
6.4 BTG Corporate
6.4.1 BTG Corporate Corporation Information
6.4.2 BTG Corporate Description and Business Overview
6.4.3 BTG Corporate Embolic Microspheres Sales, Revenue and Gross Margin (2019-2024)
6.4.4 BTG Corporate Embolic Microspheres Product Portfolio
6.4.5 BTG Corporate Recent Developments/Updates
6.5 Merit Medical Systems
6.5.1 Merit Medical Systems Corporation Information
6.5.2 Merit Medical Systems Description and Business Overview
6.5.3 Merit Medical Systems Embolic Microspheres Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Merit Medical Systems Embolic Microspheres Product Portfolio
6.5.5 Merit Medical Systems Recent Developments/Updates
6.6 ABK Biomedical
6.6.1 ABK Biomedical Corporation Information
6.6.2 ABK Biomedical Description and Business Overview
6.6.3 ABK Biomedical Embolic Microspheres Sales, Revenue and Gross Margin (2019-2024)
6.6.4 ABK Biomedical Embolic Microspheres Product Portfolio
6.6.5 ABK Biomedical Recent Developments/Updates
6.7 Terumo Corporation
6.6.1 Terumo Corporation Corporation Information
6.6.2 Terumo Corporation Description and Business Overview
6.6.3 Terumo Corporation Embolic Microspheres Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Terumo Corporation Embolic Microspheres Product Portfolio
6.7.5 Terumo Corporation Recent Developments/Updates
6.8 BioSphere Medical
6.8.1 BioSphere Medical Corporation Information
6.8.2 BioSphere Medical Description and Business Overview
6.8.3 BioSphere Medical Embolic Microspheres Sales, Revenue and Gross Margin (2019-2024)
6.8.4 BioSphere Medical Embolic Microspheres Product Portfolio
6.8.5 BioSphere Medical Recent Developments/Updates
6.9 Tepha
6.9.1 Tepha Corporation Information
6.9.2 Tepha Description and Business Overview
6.9.3 Tepha Embolic Microspheres Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Tepha Embolic Microspheres Product Portfolio
6.9.5 Tepha Recent Developments/Updates
6.10 Angio Dynamics
6.10.1 Angio Dynamics Corporation Information
6.10.2 Angio Dynamics Description and Business Overview
6.10.3 Angio Dynamics Embolic Microspheres Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Angio Dynamics Embolic Microspheres Product Portfolio
6.10.5 Angio Dynamics Recent Developments/Updates
6.11 Jiangsu Hengrui Medicine
6.11.1 Jiangsu Hengrui Medicine Corporation Information
6.11.2 Jiangsu Hengrui Medicine Embolic Microspheres Description and Business Overview
6.11.3 Jiangsu Hengrui Medicine Embolic Microspheres Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Jiangsu Hengrui Medicine Embolic Microspheres Product Portfolio
6.11.5 Jiangsu Hengrui Medicine Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Embolic Microspheres Industry Chain Analysis
7.2 Embolic Microspheres Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Embolic Microspheres Production Mode & Process
7.4 Embolic Microspheres Sales and Marketing
7.4.1 Embolic Microspheres Sales Channels
7.4.2 Embolic Microspheres Distributors
7.5 Embolic Microspheres Customers
8 Embolic Microspheres Market Dynamics
8.1 Embolic Microspheres Industry Trends
8.2 Embolic Microspheres Market Drivers
8.3 Embolic Microspheres Market Challenges
8.4 Embolic Microspheres Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
